Cargando…

Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1): A Promising Cancer Testis Antigen

Cancer has always been a huge problem in the field of human health, and its early diagnosis and treatment are the key to solving this problem. Cancer testis antigens (CTAs) are a family of multifunctional proteins that are specifically expressed in male spermatozoa and tumor cells but not in healthy...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Rui, Yuan, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JKL International LLC 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286905/
https://www.ncbi.nlm.nih.gov/pubmed/35855340
http://dx.doi.org/10.14336/AD.2021.1207
_version_ 1784748125687119872
author Bai, Rui
Yuan, Cheng
author_facet Bai, Rui
Yuan, Cheng
author_sort Bai, Rui
collection PubMed
description Cancer has always been a huge problem in the field of human health, and its early diagnosis and treatment are the key to solving this problem. Cancer testis antigens (CTAs) are a family of multifunctional proteins that are specifically expressed in male spermatozoa and tumor cells but not in healthy somatic cells. Studies have found that CTAs are involved in the occurrence and development of tumors, and some CTAs trigger immunogenicity, which suggests a possibility of tumor immunotherapy. The differential expression and function of CTAs in normal tissues and tumor cells can promote the screening of tumor markers and the development of new immunotherapies. This article introduces the expression of Kita-Kyushu lung cancer antigen-1 (KK-LC-1), a new member of the CTA family, in different types of tumors and its role in immunotherapy.
format Online
Article
Text
id pubmed-9286905
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher JKL International LLC
record_format MEDLINE/PubMed
spelling pubmed-92869052022-07-18 Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1): A Promising Cancer Testis Antigen Bai, Rui Yuan, Cheng Aging Dis Review Cancer has always been a huge problem in the field of human health, and its early diagnosis and treatment are the key to solving this problem. Cancer testis antigens (CTAs) are a family of multifunctional proteins that are specifically expressed in male spermatozoa and tumor cells but not in healthy somatic cells. Studies have found that CTAs are involved in the occurrence and development of tumors, and some CTAs trigger immunogenicity, which suggests a possibility of tumor immunotherapy. The differential expression and function of CTAs in normal tissues and tumor cells can promote the screening of tumor markers and the development of new immunotherapies. This article introduces the expression of Kita-Kyushu lung cancer antigen-1 (KK-LC-1), a new member of the CTA family, in different types of tumors and its role in immunotherapy. JKL International LLC 2022-07-11 /pmc/articles/PMC9286905/ /pubmed/35855340 http://dx.doi.org/10.14336/AD.2021.1207 Text en copyright: © 2022 Bai et al. https://creativecommons.org/licenses/by/2.0/this is an open access article distributed under the terms of the creative commons attribution license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle Review
Bai, Rui
Yuan, Cheng
Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1): A Promising Cancer Testis Antigen
title Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1): A Promising Cancer Testis Antigen
title_full Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1): A Promising Cancer Testis Antigen
title_fullStr Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1): A Promising Cancer Testis Antigen
title_full_unstemmed Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1): A Promising Cancer Testis Antigen
title_short Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1): A Promising Cancer Testis Antigen
title_sort kita-kyushu lung cancer antigen-1 (kk-lc-1): a promising cancer testis antigen
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286905/
https://www.ncbi.nlm.nih.gov/pubmed/35855340
http://dx.doi.org/10.14336/AD.2021.1207
work_keys_str_mv AT bairui kitakyushulungcancerantigen1kklc1apromisingcancertestisantigen
AT yuancheng kitakyushulungcancerantigen1kklc1apromisingcancertestisantigen